Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

[Pharmacologic treatment of multiple sclerosis].

Rivera VM.

Rev Neurol. 2001 Feb 1-15;32(3):285-8. Review. Spanish.

PMID:
11310288
2.

Multiple sclerosis: immune mechanism and update on current therapies.

Bansil S, Cook SD, Rohowsky-Kochan C.

Ann Neurol. 1995 May;37 Suppl 1:S87-101. Review.

PMID:
8968220
3.

Consensus statement of the Canadian MS CLinics Network on: the use of disease modifying agents in multiple sclerosis.

Oger J, Freedman M.

Can J Neurol Sci. 1999 Nov;26(4):274-5. Review. English, French. No abstract available.

PMID:
10610197
4.

The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.

Clerico M, Rivoiro C, Contessa G, Viglietti D, Durelli L.

Clin Neurol Neurosurg. 2008 Nov;110(9):878-85. doi: 10.1016/j.clineuro.2007.10.020. Epub 2008 Mar 4. Review.

PMID:
18164542
5.
6.

Concomitant therapy for multiple sclerosis.

Stuart WH, Vermersch P.

Neurology. 2004 Dec 14;63(11 Suppl 5):S28-34. Review.

PMID:
15596733
7.

Current approved options for treating patients with multiple sclerosis.

Rizvi SA, Agius MA.

Neurology. 2004 Dec 28;63(12 Suppl 6):S8-14. Review.

PMID:
15623672
8.

Newer long-term treatments for multiple sclerosis.

Pryse-Phillips W.

Clin Neurol Neurosurg. 2002 Jul;104(3):265-71. Review. No abstract available.

PMID:
12127666
9.

[Therapy of multiple sclerosis].

Simó M.

Neuropsychopharmacol Hung. 2009 Mar;11(1):23-6. Review. Hungarian.

10.

Multiple sclerosis.

Keegan BM, Noseworthy JH.

Annu Rev Med. 2002;53:285-302. Review.

PMID:
11818475
11.

Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.

Pula JH, Javed A.

Curr Opin Ophthalmol. 2009 Nov;20(6):476-81. doi: 10.1097/ICU.0b013e3283319155. Review.

PMID:
19816177
12.

Towards immunotherapeutic drugs and vaccines against multiple sclerosis.

Katsara M, Matsoukas J, Deraos G, Apostolopoulos V.

Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):636-42. Review.

13.

[Recent therapeutic strategy for multiple sclerosis].

Itoyama Y.

Rinsho Shinkeigaku. 2001 Dec;41(12):1214-7. Review. Japanese.

PMID:
12235841
14.

Multiple sclerosis: MHC associations and therapeutic implications.

Holmes S, Friese MA, Siebold C, Jones EY, Bell J, Fugger L.

Expert Rev Mol Med. 2005 Feb 14;7(3):1-17. Review.

PMID:
15710050
15.

Multiple sclerosis: therapeutic update.

Tselis AC, Lisak RP.

Arch Neurol. 1999 Mar;56(3):277-80. Review.

PMID:
10190816
16.

A practical guide to pediatric multiple sclerosis.

Huppke P, Gärtner J.

Neuropediatrics. 2010 Aug;41(4):157-62. doi: 10.1055/s-0030-1267155. Epub 2010 Nov 17. Review.

PMID:
21086219
17.

[Multiple sclerosis].

Offenhäusser M, Martin R.

Med Monatsschr Pharm. 1997 Jun;20(6):149-57. Review. German. No abstract available.

PMID:
9289627
18.

A practical approach to immunomodulatory therapy for multiple sclerosis.

Burks JS.

Phys Med Rehabil Clin N Am. 2005 May;16(2):449-66, ix. Review.

PMID:
15893681
19.

Toward the development of rational therapies in multiple sclerosis: what is on the horizon?

Hemmer B, Hartung HP.

Ann Neurol. 2007 Oct;62(4):314-26. Review.

PMID:
17969020
20.

[Clinical picture and therapy of multiple sclerosis].

Schrader A.

Wien Med Wochenschr. 1972 Mar 4;122(10):129-34. Review. German. No abstract available.

PMID:
4334261

Supplemental Content

Support Center